We’re excited to share that our CEO, Andrew Rosen, was recently featured on the Mission Matters podcast! In the episode, titled “Raising Awareness and Advancing Research,” Andrew discusses NAF’s commitment to accelerating treatment development, supporting families affected by Ataxia, and building a world without this devastating disease.
The conversation touches on the importance of community, the value of research partnerships, and how strategic awareness efforts are driving impact in the rare disease space. Andrew also shares insights into NAF’s evolving role as a catalyst for change and hope.
Listen to the full interview:
We’re proud to see NAF’s mission reaching new audiences and honored to be part of conversations that amplify the voices of those impacted by Ataxia.
